Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS study.
Spierings ELH, Ning X, Ramirez Campos V, Cohen JM, Barash S, Buse DC. Spierings ELH, et al. Among authors: cohen jm. Headache. 2021 Oct;61(9):1376-1386. doi: 10.1111/head.14196. Epub 2021 Aug 10. Headache. 2021. PMID: 34374086 Free PMC article. Clinical Trial.
Fremanezumab for the preventive treatment of migraine.
Silberstein SD, Cohen JM, Yeung PP. Silberstein SD, et al. Among authors: cohen jm. Expert Opin Biol Ther. 2019 Aug;19(8):763-771. doi: 10.1080/14712598.2019.1627323. Epub 2019 Jul 1. Expert Opin Biol Ther. 2019. PMID: 31177856 Clinical Trial.
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M. Ferrari MD, et al. Among authors: cohen jm. Lancet. 2019 Sep 21;394(10203):1030-1040. doi: 10.1016/S0140-6736(19)31946-4. Epub 2019 Aug 16. Lancet. 2019. PMID: 31427046 Clinical Trial.
664 results